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Risk Factors for High Mesothelial Cell Counts in 
HIV-negative Patients With Tuberculous Pleural
Effusion
Shih-Lung Cheng,1,2,3 Hao-Chien Wang,3* Pan-Chyr Yang,3 Sow-Hsong Kuo1
Background/Purpose: Higher mesothelial cell counts (HM) greater than 5% of total cell counts in tuber-
culous pleural effusions (TBPE) have been described in human immunodeficiency virus (HIV)-infected
patients, however the nature and risk factors in HIV-negative patients with TBPE are unknown. The pur-
pose of the study was to characterize the clinical manifestation of HM in HIV-negative patients with TBPE
and evaluate the risk factors of developing HM-TBPE.
Methods: This retrospective study was undertaken in HIV-negative patients with TBPE from the Far Eastern
Memorial Hospital Tuberculosis database. The cytologist and examining specialist differentiated and
quantified the cell counts. HM-TBPE was defined when more than 5% of total cell counts in the pleural fluid
were mesothelial cells. Multivariate analysis was calculated with stepwise logistic regression for HM-TBPE
risk factors.
Results: Nineteen patients were diagnosed as HM-TBPE, while 30 were diagnosed with lower mesothelial
cell counts TBPE (LM-TBPE). Compared with LM-TBPE patients, those with HM-TBPE had significantly
decreased hemoglobin and serum albumin levels (p < 0.05). Organ dysfunction such as congestive heart
failure, liver cirrhosis and renal failure was significantly more common in patients with HM-TBPE (47.4%)
than in patients with LM-TBPE (13.3%; p = 0.01). Multivariate analysis revealed that independent risk fac-
tors for developing HM-TBPE included hypoalbuminemia (odds ratio = 1.6; 95% confidence interval =
1.1–13.8) and the presence of organ dysfunction (odds ratio = 4.5; 95% confidence interval = 1.4–17.5).
Conclusion: Baseline hypoalbuminemia and comorbidities were independent risk factors for develop-
ment of HM-TBPE in HIV-negative patients. Mesothelial cell counts should not be used alone in the diag-
nosis of TBPE. An understanding of the organ dysfunction associated with HM-TBPE in HIV-negative
patients could avoid delayed diagnosis and treatment of tuberculosis.
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The first step in investigating the etiology of a pleu-
ral effusion (PE) is determining whether the effu-
sion pattern is transudate or exudate. Transudate
effusion indicates the presence of systemic disease
with repercussions on the mechanisms of pleural
fluid production and resorption.1 In contrast, ex-
udates present primary pleural disease and require
further etiological assessment.1 There is a general
consensus that malignancy is the most common
underlying cause of exudative PE (55–67%),2,3
followed by tuberculosis (TB; 12–25%).4,5 Though
differential diagnosis must be a priority, it is often
difficult to achieve due to the similar biochemical
profiles and the predominance of lymphocytes in
both conditions. When a PE is diagnosed in a pa-
tient, the need for a timely and systemic evaluation
is essential.
TB pleurisy should be considered in any patient
who exhibits exudative PE with high lymphocyte
counts. The gold standard for diagnosing pleural
TB is the identification of Mycobacterium tubercu-
losis in the pleural fluid or tissue.6 However this
method is time-consuming and not overly sensi-
tive. Cultures are positive in only one third of all
tuberculous PE (TBPE) samples and around two
thirds of pleural biopsy specimens.7,8
A pleural fluid lymphocyte count in excess of
90% of total white cells and low mesothelial cell
counts (less than 5%) is highly suggestive of TBPE.
This finding most likely reflects chronic pleural
inflammation that prevents exfoliation of meso-
thelial cells into the pleural cavity. Several bio-
logic markers such as interferon-γ and adenosine
deaminase have been demonstrated to be useful
indicators for a rapid and accurate diagnosis of
TBPE.9−13 Although the differential cell count may
reveal a predominance of neutrophils during the
initial stage of illness (about 2 weeks)14 serial tho-
racentesis show a shift towards lymphocyte pre-
dominance.15 In previous studies, the presence of
more than 5% mesothelial cells in PE samples was
usually thought to be indicative of non-TB related
PEs.16−18 However, the same types of cellular differ-
ential counts have been reported in human im-
munodeficiency virus (HIV)-positive patients.19,20
A high mesothelial cell count TBPE (HM-TBPE)
case presentation has been previously reported.21
Hence the possibility of inaccurate diagnosis and
thus delayed treatment is a concern for patients
with HM-TBPE.
We performed a retrospective study of HIV-
negative patients with TBPE diagnosis in our insti-
tution from 2006 to 2007. The aim of the present
study was to characterize the clinical manifesta-
tions of HM in patients with TBPE and evaluate
the risk factors for developing HM with TBPE.
Methods
Patients diagnosed as having TBPE from 2006 to
2007 were identified in the Far Eastern Memorial
Hospital TB database. This database records data
for all patients, including clinical features and
signs, demographic data, PE analysis, diagnosis
and treatment.
TBPE was diagnosed if either (1) culture for
M. tuberculosis of effusions or biopsy tissue samples
were positive and/or (2) caseous necrotic granu-
lomas were found in pleural biopsy tissue samples.
All possible cases, including empirical therapy
that failed to satisfy one of these criteria, were ex-
cluded from the study. All of the patients were HIV-
negative, and institutional ethics approval was
obtained for the retrospective study and informed
consent was given by each study participant.
An exudative effusion was diagnosed if the
patient meets Light’s criteria which include pleural
fluid/serum proteins >0.5 mg/dL, lactate dehydro-
genase (LDH) > 2/3 of the upper normal limit in
serum and pleural fluid/serum LDH > 0.6 IU/L.
Otherwise, PE was defined as transudate. Pleural
fluid was centrifuged (1200×g for 10 min) at 4oC.
The cellular pellet was used to quantify nucle-
ated pleural fluid cells. The cytologist and exam-
ining specialist would both differentiate and
quantify leukocyte and mesothelial cell counts.
HM-TBPE was indicated when mesothelial cells
constituted more than 5% of the total cell counts
in the pleural fluid. When the mesothelial cell
counts were less than 5%, lower mesothelial cell
counts (LM-TBPE) was diagnosed.
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Categorical variables were compared by χ2
test, and continuous variables were compared by
the Student’s t test. A p value of less than 0.05 was
considered statistically significant. Multivariate
analysis was performed with stepwise logistic re-
gression to calculate the odds ratio (OR) for HM-
TBPE risk factors. All statistical analysis was
performed by using SPSS version 9.0 (SPSS Inc.,
Chicago, IL, USA).
Results
During the 2-year study period, 49 patients were
diagnosed as having TBPE. Among these patients,
31 were diagnosed with PE positive TB culture and
five with pleural biopsy culture positivity. Caseous
necrotic granulomas were seen in pleural biopsies
from another 13 patients. Of these, 19 patients had
HM-TBPE (39%), while the remaining 30 patients
had higher lymphocyte and lower mesothelial cell
counts (61% with LM-TBPE). There were no dif-
ferences in age, gender, body mass index and dia-
betes mellitus between these two groups (Table 1).
Baseline nutritional indicators such as hemoglobin
and serum albumin levels were all significantly
decreased in HM-TBPE patients as compared with
LM-TBPE patients (Table 1). Patients with HM-
TBPE had significantly lower initial hemoglobin
and albumin levels compared with their LM-TBPE
counterparts (10.3±2.2 g/dL vs. 12.1±1.2 g/dL and
2.7±0.7g/dL vs. 3.4±0.4g/dL, respectively; p<0.05
for both comparisons). A significant higher per-
centage of patients with organ dysfunction such as
congestive heart failure (CHF), liver cirrhosis (LC)
and renal failure (RF) exhibited HM-TBPE (47.4%)
than LM-TBPE (13.3%; p = 0.01). The average me-
sothelial cell counts in patients with HM-TBPE
were significantly higher in patients with LM-TBPE
(18.3 ± 19.0% vs. 4.0 ± 3.9%, p < 0.001). Moreover,
lymphocyte cell counts in patients with HM-TBPE
were significantly lower than those in patients with
LM-TBPE (53.7 ± 21.7% vs. 93.0 ± 4.9%, p < 0.001).
The majority of effusions were exudative in both
groups. There were no between group differences
in protein or LDH levels.
Repeated thoracentesis was performed in 
19 patients with HM-TBPE. Only three patients
developed predominant lymphocyte counts
(84.2 ± 8.7%) and lower mesothelial cell counts
(6.1 ± 7.4%). Higher PE mesothelial cell counts
(16.8 ± 15.2%) were maintained in another 
Table 1. Characteristics of patients with lower and higher mesothelial cell counts in tuberculous pleural
effusion
Variables HM-TBPE (n = 19) LM-TBPE (n = 30) p
Age 56.4 ± 20.3 56 ± 25.1 0.95
Gender (M:F) 11:8 17:13 0.68
Hemoglobin (g/dL) 10.3 ± 2.2 12.1 ± 1.2 0.04†
Serum albumin (g/dL) 2.7 ± 0.7 3.4 ± 0.4 0.03†
Body mass index (kg/m2) 23.4 ± 4.7 24.7 ± 7.3 0.51
Diabetes mellitus 8 (42.1) 11 (36.7) 0.58
Organ dysfunction (CHF/LC/RF) 9 (47.4) 4 (13.3) 0.01†
Lymphocyte count in PE (%) 53.7 ± 21.7 93.0 ± 4.9 < 0.001†
Neutrophil count in PE (%) 27.5 ± 26.0 2.9 ± 3.1 < 0.001†
Mesothelial cells in PE (%) 18.3 ± 19.0 4.0 ± 3.9 < 0.001†
Exudative PE 18 (94.7) 29 (96.7) 0.89
pH in PE 7.4 ± 0.1 7.4 ± 0.2 0.93
LDH level in PE (IU/L) 346.4 ± 199.0 386.9 ± 221.0 0.52
Total protein in PE (g/dL) 5.1 ± 1.2 5.1 ± 0.9 0.91
*Data presented as n (%) or mean ± standard deviation; †statistically significant difference between groups, p < 0.05. HM-TBPE =
higher mesothelial cell counts tuberculous pleural effusion; LM-TBPE = lower mesothelial cell counts tuberculous pleural effusion;
PE = pleural effusion; CHF = congestive heart failure; LC = liver cirrhosis; RF = renal failure; LDH = lactate dehydrogenase.
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16 patients, while lymphocyte counts were rela-
tively low (61.3 ± 24.4%).
Multivariate analysis was performed to identify
the factors associated with mesothelial cell counts
in the two groups (Table 2). The independent fac-
tors identified were the presence of organ dys-
function [OR = 4.5; 95% confidence interval
(CI) = 1.4–17.5, p < 0.01] and serum albumin level
< 3.0 g/dL (OR = 1.6; 95% CI = 1.1–13.8, p < 0.01).
Low hemoglobin levels (< 11 g/dL) were found to
be associated with HM-TBPE by univariate analy-
sis. However, after adjustment for other variables,
this association was not significant (Table 2).
Patients with underlying comorbidities were
significantly older and had lower serum albumin
levels compared with patients who did not have
organ dysfunction (p = 0.002 for both, Table 3).
There was also a trend for these patients to be more
anemic; however there was no statistical difference
between the groups. Pleural fluid mesothelial cell
counts were significantly higher in TBPE patients
with comorbidities than in patients without 
comorbidities (p = 0.03; Table 3). In contrast, PE
lymphocyte counts were significantly lower in
TBPE patients with underlying comorbidities
compared with those without comorbidities
(p = 0.03; Table 3).
Discussion
The identification of M. tuberculosis in any speci-
men is sufficient for the diagnosis of TB, but this
is uncommon in pleural TB. Histologic examina-
tion of the pleura by needle biopsy is not conclu-
sive in 20–40% of patients with TBPE.22,23 When
a pleural biopsy is negative, mycobacteria can be
cultured in pleural specimens in fewer than 10%
of cases.22 The process usually takes at least 3
weeks. In previous reports, new pleural fluid lab-
oratory tests have been proposed for early and
accurate diagnosis of TBPE. However, due to the
Table 2. Multivariate analysis of risk factors for tuberculous pleural effusion in patients presenting with high
mesothelial cell counts
Variables Patients HM Univariate analysis Multivariate analysis
Age (yr)
< 65 19 7 (37.0) 0.5 (0.1–5.7) –
≥ 65 30 12 (40.0)
Hemoglobin (g/dL)
< 11 12 7 (58.3) 1.7 (1.0–9.3)† 1.3 (0.6–11.6)
≥ 11 37 12 (32.4)
Serum Albumin (g/dL)
< 3.0 14 7 (50.0) 1.9 (1.4–12.6)† 1.6 (1.1–13.8)‡
≥ 3.0 35 12 (34.3)
Body mass index (kg/m2)
< 18 13 5 (38.5) 0.8 (0.5–7.4) –
≥ 18 36 14 (38.8)
Diabetes mellitus
Yes 19 8 (42.1) 0.6 (0.1–10.7) –
No 30 11 (36.7)
Organ dysfunction§
Yes 13 9 (69.2)
No 36 10 (27.8) 4.8 (1.1–15.7)‡ 4.5 (1.4–17.5)‡
*Data presented as n, n (%) or odds ratio (95% confidence interval); †p < 0.05; ‡p < 0.01; §organ dysfunction included congestive heart
failure, liver cirrhosis and renal failure. HM = High mesothelial cell count.
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complexity of the disease, the presence or ab-
sence of a single feature does not necessarily
allow for correct diagnosis. Hence, multivariate
analyses including all surveyed variables and
biomarkers that are potential discriminators may
offer a more accurate means of diagnosis.
Stepwise diagnosis of TBPE is the same as for
any pleural exudate. An initial diagnostic tho-
racentesis is always indicated. In previous stud-
ies, analysis of mesothelial cells in PE has been
performed to rule out TBPE. Numerous studies
have confirmed that pleural fluid from patients
with TB rarely contains more than 5% mesothe-
lial cells.16,17,24,25 In this novel study we examined
patients presenting with TBPE who exhibited me-
sothelial cell counts greater than 5% in addition
to having low lymphocyte counts.
We found that the majority of patients with
hypoalbuminemia and organ dysfunction such as
CHF, LC and RF developed HM-TBPE. The aver-
age lymphocyte and mesothelial cell percentages
in these patients were 64.1% and 16.8%, respec-
tively. PE fluid from patients who had CHF, LC, or
RF was predominately transudative in character.
It has previously been shown that the differential
cell counts in such transudative PEs consist of pre-
dominantly polymorphonuclear leukocytes, small
lymphocytes and some mesothelial cells.24 We
hypothesized that the simultaneous conditions of
TBPE and induced-transudative PE may interfere
and modify the complexity of the pleural fluid,
resulting in higher mesothelial cell counts and
lower lymphocyte counts as compared with pleu-
ral fluid associated with typical TBPE. More at-
tention should be given to this phenomenon in
the initial analysis of PE cell differentiation.
In previous reports, typical TBPE presentations
included an exudate rich in lymphocytes with less
than 5% mesothelial cells. In the present study,
this was only observed in patients with normal al-
bumin levels or without organ dysfunction. How-
ever, the manifestation of high mesothelial cells
with TBPE is sometimes detected in clinical prac-
tice and has been reported previously.21 Atypical
differential cell counts upon presentation of TBPE
may lead to erroneous diagnosis and treatment,
especially in patients with poor nutritional status
or comorbidities. Therefore, it is important in
many settings that TBPE patients are not treated
initially because of the absence of predominant
lymphocytes and the scarcity of mesothelial cells
in PEs. We suggest that available molecular tech-
niques and biomarkers for pleural fluid specimens
should be evaluated further in this situation in
order to increase the diagnostic accuracy of TBPE.
The use of mesothelial cell counts has be-
come standard practice when considering TB in
the differential diagnosis of a PE.16,17 It is worth
Table 3. Demographic data and characteristics in patients with tuberculous pleural effusion with and without
organ dysfunction
Variables
Patients with organ Patients without organ 
p
dysfunction (n = 13) dysfunction (n = 36)
Age (yr) 71.83 ± 11.92 50.21 ± 23.17 0.002†
Gender (M:F) 7:6 19:17 0.87
Hemoglobin (g/dL) 11.74 ± 1.62 12.25 ± 1.36 0.24
Serum albumin (g/dL) 2.85 ± 0.51 3.57 ± 0.52 0.002†
BMI (kg/m2) 23.96 ± 4.33 24.65 ± 7.11 0.47
Neutrophil count in PE (%) 19.13 ± 24.55 12.63 ± 19.91 0.14
Mesothelial cells in PE (%) 16.84 ± 17.91 5.53 ± 8.35 0.03†
Lymphocyte count in PE (%) 64.13 ± 25.46 81.84 ± 23.47 0.03†
pH in PE 7.44 ± 0.18 7.41 ± 0.21 0.93
LDH level in PE (IU/L) 319.56 ± 200.33 409.17 ± 210.21 0.19
Total protein in PE (g/dL) 4.69 ± 1.45 5.38 ± 0.92 0.06
*Data presented as mean ± standard deviation; †statistically significant difference between groups, p < 0.05. BMI = body mass index;
PE = pleural effusion; LDH = lactate dehydrogenase.
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nothing that there have been reports of numerous
mesothelial cells in tuberculous PEs in patients
diagnosed with HIV.19,26,27 The pathogenesis of
large quantities of mesothelial cells in TBPE in
HIV-infected patients may result from an alterna-
tion in the immune response, such as decreased
expression of macrophage inflammatory protein-
1α and interferon-γ,28,29 which could lead to the
exfoliation of mesothelial cells into the pleural
cavity. In fact, macrophage stimulated meso-
thelial cell interleukin-8 production has been re-
ported.30 The immune response of mesothelial
cells in TBPE should be further elucidated in the
future.
In conjunction with measurements of pleural
fluid proteins and LDH, which is important in
patients with hypoalbuminemia or organ dysfunc-
tion, additional diagnostic studies should be per-
formed if the pleural fluid does not meet the
transudative criteria. In our study, the characteris-
tics of PEs almost displayed an exudative pattern in
patients with HM-TBPE and organ dysfunction.
This finding can serve to remind clinicians that
TBPE remains a diagnostic probability in these
high risk patients even when PE lymphocytes are
low and significant mesothelial cells are high.
Our study is limited by its retrospective na-
ture and relatively small sample size. Further
prospective studies with larger populations and
more laboratory investigations should be con-
ducted to elucidate the nature of the immuno-
logical pathogenesis of HM-TBPE.
In conclusion, we have described the clinical
presentations in HIV-negative patients with HM-
TBPE. These characteristics included malnutri-
tion, anemia, especially hypoalbuminemia and
co-existing organ dysfunction. These may interfere
with the interpretation of PE due to immunolog-
ical alternations or transudate pattern modifica-
tion. Mesothelial cell counts in PE should not be
used alone in the diagnosis of TBPE. These find-
ings are useful for clinical practice in the initial
differential diagnosis for the etiology of PEs and
aid clinicians in performing further diagnostics
procedures to improve diagnostic accuracy of
TBPE. An understanding of the manifestations and
risk factors of HM-TBPE could prevent delayed
diagnosis and treatment of TB.
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